On CNBC’s “Fast Money Halftime Report,” Jason Snipe spoke about Facebook, Inc. Common Stock (NASDAQ:FB). He said the company had a really strong quarter, but there might be some potential headwinds. He would hold the stock and buy more on weakness.
Carter Worth And Mike Khouw’s XBI Trade
On CNBC's "Options Action," Carter Worth of Cornerstone Macro said SPDR S&P Biotech ETF (NYSE: XBI) has a bounce potential, having sold off to support.
